Drugs@FDA document
RETIN-A MICRO Letter · NDA 020475 SUPPL-36
Drugs@FDA document · BAUSCH · Apr 7, 2026
Key facts
| Drug name | RETIN-A MICRO |
|---|---|
| Document type | Letter |
| Application | NDA020475 |
| Submission | SUPPL-36 |
| Company | BAUSCH |
| Document date | Apr 7, 2026 |
| FDA document | accessdata.fda.gov |
At a glance
- Manufacturing (CMC)-Control Document categories
- 1–9 Documents for this application
- None USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: